Skip to main content

Table 1 Key data attributes

From: Review and analysis of the overlapping threats of carbapenem and polymyxin resistant E. coli and Klebsiella in Africa

Age group

Number (%)

Population type

Number (%)

Study type

Number (%)

Specimen type

Number (%)

Specimen type

Number (%)

Species

Number (%)

Adolescent

37 (2.5%)

Community

429 (29.0%)

Case series

334 (22.6%)

Ascitic fluid

3 (0.2%)

Pus

17 (1.2%)

E. coli a

692 (46.8%)

Adult

299 (20.2%)

HC-acute

1234 (83.4%)

Clinical lab

998 (67.5%)

Aspirate

1 (0.1%)

Rectal

1 (0.1%)

K. spp. b

787 (53.2%)

All

444 (30.0%)

HC-long

8 (0.5%)

Outbreak

29 (2.0%)

BAL

1 (0.1%)

Respiratory

6 (0.4%)

  

Child

194 (13.1%)

HC-unknown

62 (4.2%)

Surveillance

121 (8.2%)

Bedsore

1 (0.1%)

Sperm

1 (0.1%)

  

Elderly

16 (1.1%)

Travelers

15 (1.0%)

  

Blood

304 (20.6%)

Sputum

9 (0.6%)

  

Infant

56 (3.8%)

Unknown

25 (1.7%)

  

Catheter

2 (0.1%)

Stool

184 (12.4%)

  

Neonate

61 (4.1%)

    

Cervicovaginal

2 (0.1%)

Tissue

7 (0.5%)

  

Unknown

506 (34.2%)

    

CSF

8 (0.5%)

Umbilical

1 (0.1%)

  
      

Ear

6 (0.4%)

Unknown

62 (4.2%)

  
      

Endocervical

2 (0.1%)

Urine

345 (23.3%)

  
      

Endotracheal

3 (0.2%)

Vaginal

7 (0.5%)

  
      

ETA

4 (0.3%)

Wound

69 (4.7%)

  
      

Gastric fluid

2 (0.1%)

    
      

Hand

3 (0.2%)

    
      

IV fluid

1 (0.1%)

    
      

Multiple

512 (34.6%)

    
      

Nasal

7 (0.5%)

    
      

Otitis media

2 (0.1%)

    
      

Peritoneal fluid

11 (0.7%)

    
      

Peritoneum

1 (0.1%)

    
  1. Numbers and % of 1479 unique data reports including the indicated subgroups. In some categories total is > 1479 as reports may contain multiple subgroups
  2. aEscherichia coli
  3. bKlebsiella spp.